Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2838232 + Cobicistat in HIV-1
NCT03045861Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of GSK2838232 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by GSK. Started Mar 2017; status: completed.
02
Drugs
GSK2838232
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03045861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03045861.